Alex Louie MD, PhD
@DrAlexLouie
Followers
2K
Following
11K
Statuses
1K
radiation oncologist | sushi snob | pizza purveyor | raptors reveller | views my own 🇨🇦
Toronto, Ontario
Joined April 2013
RT @SABRCanada: 🙋♀️ Register for the 2025 @SABRCanada Conference! 🌍 and 🇨🇦 faculty including: @ShankarSiva
@ldaw…
0
4
0
RT @drdavidpalma: Growing evidence for using sim-free RT for palliative cases...here's the SFRT-1000 study from @th1loz in @IJROBP. Plann…
0
35
0
RT @_ShankarSiva: 📢🚨 Hot off the press @TheLancetOncol for #kidneycancer! SABR vs thermal ablation; - Despite ⏫age…
0
104
0
RT @gerryhanna: Interesting paper just out in @JCO_ASCO Chinese study in patients with EGFR positive oligo-organ metastatic #NSCLC. TKI p…
0
26
0
RT @SahgalArjun: @ISRSy guideline for SBRT to non spine bone metastases is published as pre proof in @RO_GreenJournal. Thanks to Dr. Tim Ng…
0
26
0
RT @gusviani: 🚨Breaking Barriers in Global Oncology❗️@OncoAlert @TheLancetOncol @fabiomoraesmd @RadioOncologia We proudly introduce the…
0
30
0
RT @CJTsaiMDPhD: Congrats to @r_glicksman and the team @RadMedPM @RMPCRProgram @pmcancercentre for publishing this Ph2 single arm study of…
0
30
0
RT @jryckman3: 🎉 Excited to share our latest work: RadOncCalc – A Mobile-Friendly Tool to Enhance Radiation Oncology Practice 📱⚛️ How does…
0
99
0
RT @JordiRemon: 2024: Fortunately is difficult to merge all ttx for NSCLC 🫁 in 1 slide. Hwv, still pending: ✏️avoid “me too” approvals if p…
0
121
0
1
0
1
RT @Mat_Guc: Randomized comparison of SBRT vs RFA for recurrent small HCC (n=166 pts) - Freedom from local progression significantly improv…
0
40
0
RT @StephenVLiu: Phase II study @TheLancetOncol for unresectable stage III NSCLC: SBRT to primary then chemoradiation to nodes then durvalu…
0
16
0
RT @cristian_udo: Should prostate RT be an option for all men with de novo mCSPC (high and low volume), despite systemic intensification? C…
0
40
0
Thanks to @StephenChunMD @AndrearicFili @samsonpp for leading our annual @IASLC #radonc webinar on controversial cases in stage III NSCLC! 🫁☢️⚡️#lcsm
1
11
34
RT @Mat_Guc: Must read clinical trials in the field of #SBRT 2024 Please complement the list, to allow us staying up-to-date ! https://t.c…
0
95
0
RT @_ShankarSiva: "Oligo"-no more! 🇨🇦ARREST phase I out now @IJROBP - @sueyom ➡️SABR to median=16 "poly"metastases in patients who had al…
0
79
0
0
9
0
RT @_ShankarSiva: 🇫🇷#SFRO2024 - @Mat_Guc gives an important update on E2Radiate registry and OligoCare cohort; run-rate 80 patients per mon…
0
14
0